CORT vs. SHOO

Last updated Jun 9, 2026

CORT (Corcept Therapeutics Incorporated) and SHOO (Steven Madden, Ltd.) are both stocks. CORT operates in Biotechnology (Healthcare), while SHOO operates in Footwear & Accessories (Consumer Cyclical). Over the past 10 years, CORT returned 29.33%/yr vs 8.85%/yr for SHOO. At a 0.18 correlation, their price movements are largely independent.

Performance

CORT vs. SHOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and Steven Madden, Ltd. (SHOO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CORT achieves a 110.72% return, which is significantly higher than SHOO's 10.00% return. Over the past 10 years, CORT has outperformed SHOO with an annualized return of 29.33%, while SHOO has yielded a comparatively lower 8.85% annualized return.

CORT

• 1D: 0.98%
• 1M: 40.26%
• YTD: 110.72%
• 6M: -11.63%
• 1Y: 5.36%
• 3Y*: 46.50%
• 5Y*: 27.35%
• 10Y*: 29.33%

SHOO

• 1D: 3.40%
• 1M: 12.11%
• YTD: 10.00%
• 6M: 6.84%
• 1Y: 87.20%
• 3Y*: 13.37%
• 5Y*: 2.86%
• 10Y*: 8.85%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CORT vs. SHOO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CORT Corcept Therapeutics Incorporated	110.72%	-30.94%	55.14%	59.92%	2.58%	-24.31%	116.20%	-9.43%	-26.02%	148.76%
SHOO Steven Madden, Ltd.	10.00%	0.63%	3.21%	34.62%	-29.52%	33.46%	-17.43%	44.42%	-1.19%	30.63%

Correlation

The correlation between CORT and SHOO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.23
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004	0.18

Fundamentals

Market Cap CORT : $7.66B SHOO : $3.26B
EPS CORT : $0.41 SHOO : $1.07
PE Ratio CORT : 178.81 SHOO : 42.47
PS Ratio CORT : 11.07 SHOO : 1.23
PB Ratio CORT : 12.00 SHOO : 3.57
Total Revenue (TTM) CORT : $769.10M SHOO : $2.63B
Gross Profit (TTM) CORT : $755.64M SHOO : $1.18B
EBITDA (TTM) CORT : $3.66M SHOO : $148.60M

Return for Risk

CORT vs. SHOO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CORT

CORT Risk / Return Rank: 47
CORT Sharpe Ratio Rank: 44
CORT Sortino Ratio Rank: 47
CORT Omega Ratio Rank: 56
CORT Calmar Ratio Rank: 44
CORT Martin Ratio Rank: 44

SHOO

SHOO Risk / Return Rank: 84
SHOO Sharpe Ratio Rank: 89
SHOO Sortino Ratio Rank: 84
SHOO Omega Ratio Rank: 83
SHOO Calmar Ratio Rank: 82
SHOO Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CORT vs. SHOO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Steven Madden, Ltd. (SHOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CORT	SHOO	Difference
Sharpe ratio: Return per unit of total volatility	0.07	1.96	-1.89
Sortino ratio: Return per unit of downside risk	0.66	2.54	-1.88
Omega ratio: Gain probability vs. loss probability	1.14	1.33	-0.19
Calmar ratio: Return relative to maximum drawdown	0.08	2.76	-2.68
Martin ratio: Return relative to average drawdown	0.15	7.31	-7.16
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CORT vs. SHOO - Sharpe Ratio Comparison

The current CORT Sharpe Ratio is 0.07, which is lower than the SHOO Sharpe Ratio of 1.96. The chart below compares the historical Sharpe Ratios of CORT and SHOO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CORT	SHOO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.07	1.96	-1.89
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.37	0.07	+0.30
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.44	0.22	+0.22
Sharpe Ratio (All Time) Calculated using the full available price history	0.11	0.20	-0.09

Drawdowns

CORT vs. SHOO - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.28%, which is greater than SHOO's maximum drawdown of -77.06%. Use the drawdown chart below to compare losses from any high point for CORT and SHOO.

Drawdown Indicators

	CORT	SHOO	Difference
Max Drawdown Largest peak-to-trough decline	-94.28%	-77.06%	-17.22%
Max Drawdown (1Y) Largest decline over 1 year	-64.40%	-31.73%	-32.67%
Max Drawdown (3Y) Largest decline over 3 years	-71.85%	-60.21%	-11.64%
Max Drawdown (5Y) Largest decline over 5 years	-71.85%	-60.21%	-11.64%
Max Drawdown (10Y) Largest decline over 10 years	-71.85%	-60.21%	-11.64%
Current Drawdown Current decline from peak	-35.80%	-4.84%	-30.96%
Average Drawdown Average peak-to-trough decline	-53.44%	-22.85%	-30.59%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.34%	11.97%	+23.37%

Volatility

CORT vs. SHOO - Volatility Comparison

Corcept Therapeutics Incorporated (CORT) has a higher volatility of 16.41% compared to Steven Madden, Ltd. (SHOO) at 9.99%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than SHOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CORT	SHOO	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.41%	9.99%	+6.42%
Volatility (6M) Calculated over the trailing 6-month period	85.07%	30.33%	+54.74%
Volatility (1Y) Calculated over the trailing 1-year period	76.73%	44.82%	+31.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	74.52%	39.12%	+35.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	67.22%	40.39%	+26.83%

Dividends

CORT vs. SHOO - Dividend Comparison

CORT has not paid dividends to shareholders, while SHOO's dividend yield for the trailing twelve months is around 2.32%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
CORT Corcept Therapeutics Incorporated	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SHOO Steven Madden, Ltd.	2.32%	2.02%	1.98%	2.00%	2.63%	1.29%	0.42%	1.33%	1.78%

Financials

CORT vs. SHOO - Profitability Comparison

The chart below illustrates the profitability comparison between Corcept Therapeutics Incorporated and Steven Madden, Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.

SHOO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Steven Madden, Ltd. reported a gross profit of 357.42M and revenue of 653.10M. Therefore, the gross margin over that period was 54.7%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.

SHOO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Steven Madden, Ltd. reported an operating income of 98.74M and revenue of 653.10M, resulting in an operating margin of 15.1%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.

SHOO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Steven Madden, Ltd. reported a net income of 71.82M and revenue of 653.10M, resulting in a net margin of 11.0%.

Frequently Asked Questions

Can I hold both CORT and SHOO in my portfolio?

CORT and SHOO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CORT or SHOO?

CORT has higher volatility (16.41%) compared to SHOO (9.99%). In terms of maximum drawdown, CORT dropped -94.28% vs SHOO's -77.06%.

Which has better risk-adjusted returns?

SHOO currently has the higher Sharpe Ratio (1.96 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.